PT1451181E - Compostos diméricos e sua utilização como agentes antivirais - Google Patents
Compostos diméricos e sua utilização como agentes antivirais Download PDFInfo
- Publication number
- PT1451181E PT1451181E PT02771913T PT02771913T PT1451181E PT 1451181 E PT1451181 E PT 1451181E PT 02771913 T PT02771913 T PT 02771913T PT 02771913 T PT02771913 T PT 02771913T PT 1451181 E PT1451181 E PT 1451181E
- Authority
- PT
- Portugal
- Prior art keywords
- viral agents
- dimeric compounds
- compounds
- amino
- trifluoroacetyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000003443 antiviral agent Substances 0.000 title 1
- 108010016626 Dipeptides Proteins 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 abstract 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 125000006367 bivalent amino carbonyl group Chemical group [H]N([*:1])C([*:2])=O 0.000 abstract 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 abstract 1
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Pyrane Compounds (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPR8794A AUPR879401A0 (en) | 2001-11-09 | 2001-11-09 | Novel chemical compounds and their use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1451181E true PT1451181E (pt) | 2008-10-01 |
Family
ID=3832613
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT02771913T PT1451181E (pt) | 2001-11-09 | 2002-11-08 | Compostos diméricos e sua utilização como agentes antivirais |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US7223790B2 (enExample) |
| EP (1) | EP1451181B1 (enExample) |
| JP (2) | JP2005508989A (enExample) |
| KR (1) | KR101002794B1 (enExample) |
| CN (1) | CN100526309C (enExample) |
| AT (1) | ATE399780T1 (enExample) |
| AU (1) | AUPR879401A0 (enExample) |
| CA (1) | CA2463865C (enExample) |
| DE (1) | DE60227409D1 (enExample) |
| DK (1) | DK1451181T3 (enExample) |
| ES (1) | ES2307793T3 (enExample) |
| PT (1) | PT1451181E (enExample) |
| WO (1) | WO2003040137A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4535713B2 (ja) * | 2003-10-30 | 2010-09-01 | 株式会社ヤクルト本社 | 抗ヒトサイトメガロウイルス剤 |
| US20070094334A1 (en) * | 2005-10-21 | 2007-04-26 | Microsoft Corporation | Service/client synchronization |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9516276D0 (en) * | 1995-08-08 | 1995-10-11 | Biota Scient Management | Chemical compounds |
| US6242582B1 (en) * | 1996-03-01 | 2001-06-05 | Biota Scientific Management Pty Ltd. | Method of detection of influenza virus and compounds for use therein |
| TR199901081T2 (xx) | 1996-11-14 | 1999-08-23 | Biota Scientific Management Pty.Ltd. | Y�ntem ve bu y�ntemde kullan�lan yeni bile�imler. |
| AUPP913999A0 (en) | 1999-03-12 | 1999-04-01 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
| AUPR001000A0 (en) | 2000-09-08 | 2000-10-05 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
-
2001
- 2001-11-09 AU AUPR8794A patent/AUPR879401A0/en not_active Abandoned
-
2002
- 2002-11-08 DE DE60227409T patent/DE60227409D1/de not_active Expired - Lifetime
- 2002-11-08 US US10/494,260 patent/US7223790B2/en not_active Expired - Fee Related
- 2002-11-08 AT AT02771913T patent/ATE399780T1/de not_active IP Right Cessation
- 2002-11-08 PT PT02771913T patent/PT1451181E/pt unknown
- 2002-11-08 KR KR1020047006447A patent/KR101002794B1/ko not_active Expired - Fee Related
- 2002-11-08 EP EP02771913A patent/EP1451181B1/en not_active Expired - Lifetime
- 2002-11-08 CA CA2463865A patent/CA2463865C/en not_active Expired - Fee Related
- 2002-11-08 ES ES02771913T patent/ES2307793T3/es not_active Expired - Lifetime
- 2002-11-08 DK DK02771913T patent/DK1451181T3/da active
- 2002-11-08 WO PCT/AU2002/001527 patent/WO2003040137A1/en not_active Ceased
- 2002-11-08 JP JP2003542183A patent/JP2005508989A/ja active Pending
- 2002-11-08 CN CNB028222482A patent/CN100526309C/zh not_active Expired - Fee Related
-
2007
- 2007-04-12 US US11/734,394 patent/US7468388B2/en not_active Expired - Fee Related
-
2010
- 2010-07-16 JP JP2010161620A patent/JP2011016804A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| US20070225358A1 (en) | 2007-09-27 |
| EP1451181A1 (en) | 2004-09-01 |
| DE60227409D1 (de) | 2008-08-14 |
| ATE399780T1 (de) | 2008-07-15 |
| DK1451181T3 (da) | 2008-11-03 |
| US20050054719A1 (en) | 2005-03-10 |
| AUPR879401A0 (en) | 2001-12-06 |
| KR101002794B1 (ko) | 2010-12-21 |
| US7223790B2 (en) | 2007-05-29 |
| KR20050044340A (ko) | 2005-05-12 |
| CA2463865A1 (en) | 2003-05-15 |
| EP1451181A4 (en) | 2005-02-02 |
| JP2005508989A (ja) | 2005-04-07 |
| US7468388B2 (en) | 2008-12-23 |
| JP2011016804A (ja) | 2011-01-27 |
| CA2463865C (en) | 2011-09-27 |
| ES2307793T3 (es) | 2008-12-01 |
| WO2003040137A1 (en) | 2003-05-15 |
| HK1068347A1 (en) | 2005-04-29 |
| CN1585766A (zh) | 2005-02-23 |
| CN100526309C (zh) | 2009-08-12 |
| EP1451181B1 (en) | 2008-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2086654A1 (en) | Novel pharmaceutically active 1,2,4-triaminobenzene derivatives, processes for their preparation and pharmaceutical compositions containing them | |
| EP2341065A3 (en) | Inhibitors of serine proteases, particularly HCV NS3-NS4a protease | |
| IL205420A (en) | Immunogoldular and Derivative Compounds, Pharmaceutical Compounds in the Treatment of Inflammatory Stomach and Gastrointestinal Disorders | |
| DE602004023924D1 (en) | Ease-hemmer | |
| TW200510391A (en) | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease | |
| GEP20053619B (en) | Pyrazole Derivatives for Treating HIV | |
| AU2134402A (en) | Antiviral agents | |
| JP2006527185A5 (enExample) | ||
| DE60035429D1 (de) | Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen | |
| MY141506A (en) | Virus therapeutic drug | |
| PT1451181E (pt) | Compostos diméricos e sua utilização como agentes antivirais | |
| GEP20115240B (en) | Indole derivatives, process for their preparation and pharmaceutical compositions containing them | |
| EP1451184A4 (en) | DIMERED COMPOUNDS AND THEIR USE AS ANTIVIRAL AGENTS | |
| EP1078635A3 (en) | Medicaments comprising sialic acid derivatives as active ingredients | |
| ATE301997T1 (de) | Antivirale therapie | |
| PL304334A1 (en) | Pharmaceutical composition of gastric protective action, including antiulceric one and method of treating diseases of gastrointestinal tract | |
| GB0223234D0 (en) | Chemical compounds | |
| BRPI0509533A (pt) | compostos de agentes antivirais, composição farmacêutica e seus usos | |
| DE60104288D1 (de) | Antivirale therapie | |
| GEP20053513B (en) | 2-Aminocarbonyl-9H-Purine Derivatives | |
| GB0125658D0 (en) | Medicaments | |
| TH51768A (th) | สารประกอบคาร์บาฟีเนม การใช้ของสารดังกล่าว และสารประกอบตัวกลางสำหรับสารดังกล่าว |